Immunic Therapeutics

Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company.

HQ location

New York City, United States

Founding location

Munich, Germany

Website

Launch date

Apr 2016

Employees

Enterprise value

$44—66m

https://twitter.com/immunic_ag https://www.linkedin.com/company/immunic-therapeutics/

Authorizing premium user...